The Medipattern Corporation
TSX VENTURE : MKI

The Medipattern Corporation

June 19, 2008 06:30 ET

Medipattern Attracts Significant Industry Experience to Management Team

TORONTO, ONTARIO--(Marketwire - June 19, 2008) -

Attention: Business/Financial Editors:

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce the addition of two leading industry professionals, Cindy Rapp and Bob Dockendorff to Medipattern's management team. Ms. Rapp will assume the position of Vice President, Clinical Program Development where her primary focus will be to expand and enhance Medipattern's Continuing Medical Education (CME) training programs as well as luminary support, clinical trials and reseller product training. Mr. Dockendorff will take on the role of Vice President, Sales. Janet Sterritt, Medipattern's current Vice President, Sales and Marketing, will shift her focus to identifying new products and markets as Vice President, Business Strategy and Marketing.

Ms. Rapp, BS, RDMS, FSDMS, FAIUM, has been involved in sonography for approximately 25 years. An active member of the Society of Diagnostic Medical Sonography (SDMS) and the American Institute of Ultrasound in Medicine (AIUM), Ms. Rapp received Fellowship into both organizations in 2001. She is also actively involved with the American Registry of Diagnostic Medical Sonographers (ARDMS), where she chaired the task force for the Breast Ultrasound Registry. Ms. Rapp routinely lectures nationally and internationally on various ultrasound topics with an expressed emphasis in breast sonography. She has authored numerous sonographic chapters, articles and award winning scientific exhibits. In 2000, she received the prestigious Kenneth R. Gottesfeld award of excellence for her publication in the JDMS "Ultrasound of Abdominal Wall Hernias". Ms. Rapp received the distinguished sonographer of the year award from the AIUM in 2005 and will receive the Joan P. Baker Pioneer Award at this years SDMS annual conference in October.

Mr. Dockendorff brings to Medipattern more than 26 years of sales, industry, and leadership experience with large, small, and start-up companies in the medical technology and imaging sector. From 1981-2003, Mr. Dockendorff was with ATL Ultrasound and later Philips Medical Systems where he rose through the ranks of the company to the position of Vice President. He led a sales team that repeatedly achieved record results and became the top sales organization in the industry. His innovative approach drove the creation of a number of corporate and industry firsts, including dedicated sales of refurbished equipment, a 'technology-refresh' long-term contract arrangement that provided significant advantages to both the customer and to the equipment supplier, flexed service contracts to recognize the needs of large users, and introduced nationwide sales training in order to create a common language focusing on customer needs rather than discount selling. In 2003, Mr. Dockendorff joined CIVCO Medical, a manufacturer and distributor of products for ultrasound diagnostic and therapeutic procedures for cardiology, radiology, and urology, where he built a highly successful international sales team and established strategic partnerships with ultrasound industry leaders GE, Philips, Siemens, and Toshiba. His achievements at CIVCO led him to U-Systems, Inc., where he was brought on board to develop a worldwide sales and marketing strategy to introduce automated breast ultrasound to the radiology and breast surgery market. Mr. Dockendorff's disciplined approach and leadership skills were developed prior to his career in the medical imaging industry as a Captain with the United States Marine Corps.

"Medipattern has been very successful in recruiting some of the top people in the medical imaging industry and we could not be more pleased with the additions of Cindy and Bob to the team," stated Jeff Collins, CEO of The Medipattern Corporation. "Their experience, individual achievements, and exceptional reputations in the industry further enhance the Medipattern brand, as well as our ability to expand our technology and product platform into new markets."

Upcoming Events:

Medipattern will participate in the following events:

- Chicago International Breast Course, September 11 to 14, Chicago, IL, USA

- Radiological Society of North America (RSNA), November 30 to December 5, Chicago, IL, USA

The Medipattern Corporation

Medipattern develops computer-aided detection (CAD) solutions for medical imaging. These products enhance workflow while improving interpretive and diagnostic confidence. The Company's initial clinical applications are B-CAD™ for breast ultrasound and B-CADMRI™. Both have received awards for innovation in the industry. The B-CAD products, part of the Company's CADENZA™ platform, use pattern recognition technology to assist radiologists in their efforts to classify and characterize lesions in medical images. Please visit the Company's website at: www.medipattern.com.

B-CAD™ and B-CADMRI™ are trademarks of The Medipattern Corporation.
Medipattern® is a registered mark of The Medipattern Corporation.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved of the contents of this release.

Contact Information